HROW Q4 2024 Earnings — Harrow Health, Inc. Revenue & Financial Results | Market Cap Arena

HROWHarrow Health, Inc.

$1B

Q4 2024 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$67M+83.8% YoY

Gross Profit

$53M78.8% margin

Operating Income

$13M19.3% margin

Net Income

$7M10.1% margin

EPS (Diluted)

$0.19

QoQ Revenue Growth

+35.7%

Cash Flow

Operating Cash Flow

-$18M

Free Cash Flow

-$55M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$389M

Total Liabilities

$320M

Stockholders' Equity

$70M

Cash & Equivalents

$47M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$67M	$36M	+83.8%
Gross Profit	$53M	$25M	+110.3%
Operating Income	$13M	-$5M	+364.6%
Net Income	$7M	-$9M	+174.1%

Revenue Segments

Other Revenue

$687,000100%